179 related articles for article (PubMed ID: 33688858)
1. Modeling Acute Pericarditis: An Inflammatory Step Toward Tailored Therapeutic Strategies.
Silvestre JS
JACC Basic Transl Sci; 2021 Feb; 6(2):151-153. PubMed ID: 33688858
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin-1.
Del Buono MG; Bonaventura A; Vecchié A; Moroni F; Golino M; Bressi E; De Ponti R; Dentali F; Montone RA; Kron J; Lazzerini PE; Crea F; Abbate A
Eur J Clin Invest; 2024 Feb; 54(2):e14110. PubMed ID: 37837616
[TBL] [Abstract][Full Text] [Related]
3. The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches.
Mauro AG; Bonaventura A; Vecchié A; Mezzaroma E; Carbone S; Narayan P; Potere N; Cannatà A; Paolini JF; Bussani R; Montecucco F; Sinagra G; Van Tassel BW; Abbate A; Toldo S
JACC Basic Transl Sci; 2021 Feb; 6(2):137-150. PubMed ID: 33665514
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease.
Vecchié A; Del Buono MG; Chiabrando GJ; Dentali F; Abbate A; Bonaventura A
Curr Cardiol Rep; 2021 Oct; 23(11):157. PubMed ID: 34599390
[TBL] [Abstract][Full Text] [Related]
5. Advances in pharmacotherapy for acute and recurrent pericarditis.
Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments.
Bizzi E; Trotta L; Pancrazi M; Nivuori M; Giosia V; Matteucci L; Montori D; Brucato A
Curr Cardiol Rep; 2021 Jul; 23(9):128. PubMed ID: 34319478
[TBL] [Abstract][Full Text] [Related]
7. The inflammasome as a therapeutic target for myopericardial diseases.
Imazio M; Abbate A
Minerva Cardiol Angiol; 2022 Apr; 70(2):238-247. PubMed ID: 35412034
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 Blockers in Recurrent and Acute Pericarditis: State of the Art and Future Directions.
Gallo A; Massaro MG; Camilli S; Di Francesco S; Gerardino L; Verrecchia E; Sicignano LL; Landi F; Manna R; Montalto M
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399529
[TBL] [Abstract][Full Text] [Related]
9. New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.
Xu B; Harb SC; Cremer PC
Curr Cardiol Rep; 2017 Jul; 19(7):60. PubMed ID: 28528454
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.
Ammirati E; Bizzi E; Veronese G; Groh M; Van de Heyning CM; Lehtonen J; Pineton de Chambrun M; Cereda A; Picchi C; Trotta L; Moslehi JJ; Brucato A
Front Med (Lausanne); 2022; 9():838564. PubMed ID: 35350578
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and pericarditis: Are neutrophils actors behind the scenes?
Bonaventura A; Montecucco F
J Cell Physiol; 2019 May; 234(5):5390-5398. PubMed ID: 30417336
[TBL] [Abstract][Full Text] [Related]
12. Relapsing pericarditis: Peripheral blood neutrophilia, lymphopenia and high neutrophil-to-lymphocyte ratio herald acute attacks, high-grade inflammation, multiserosal involvement, and predict multiple recurrences.
Tombetti E; Casarin F; Bizzi E; Bezer S; Mascolo R; Pallini G; Gabiati C; Bonaventura A; Trotta L; Pancrazi M; Maestroni S; Brucato A
Int J Rheum Dis; 2023 Feb; 26(2):337-343. PubMed ID: 36537284
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation.
Parent S; Vaka R; St Amant J; Kahn S; Van Remortel S; Bi C; Courtman D; Stewart DJ; Davis DR
Theranostics; 2024; 14(2):608-621. PubMed ID: 38169629
[No Abstract] [Full Text] [Related]
14. Management of acute pericarditis.
Avula S; Madsen N
Curr Opin Cardiol; 2023 Jul; 38(4):364-368. PubMed ID: 37115909
[TBL] [Abstract][Full Text] [Related]
15. An update on the pathophysiology of acute and recurrent pericarditis.
Bonaventura A; Vecchié A; Mauro AG; Brucato AL; Imazio M; Abbate A
Panminerva Med; 2021 Sep; 63(3):249-260. PubMed ID: 33337127
[TBL] [Abstract][Full Text] [Related]
16. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
[TBL] [Abstract][Full Text] [Related]
18. [Pericarditis is inflammation of the pericardium, which rheumatologists should know].
Krusche M; Schneider U; Ruffer N
Z Rheumatol; 2021 Feb; 80(1):54-64. PubMed ID: 33216192
[TBL] [Abstract][Full Text] [Related]
19. Pericarditis and pericardial effusion: one or two distinct diseases?
Lazaros G; Lazarou E; Vlachopoulos C; Antonopoulos A; Tsioufis K
Minerva Cardiol Angiol; 2022 Apr; 70(2):207-216. PubMed ID: 34338486
[TBL] [Abstract][Full Text] [Related]
20. Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.
Dong T; Klein AL; Wang TKM
Curr Cardiol Rep; 2023 Sep; 25(9):993-1000. PubMed ID: 37458866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
